Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Association of the HLA-DR4 gene complex with auto-antibodies in rheumatoid arthritis patients
Modern Rheumatology, 06/18/09
Xinping T et al. - Although DR4 is an important indicator for severe rheumatoid arthritis (RA) and poor prognosis, it is only associated with rheumatoid factor (RF). Moreover, no correlation could be found between these auto-antibodies.
Methods- Aim was to investigate in RA pts (n=45) the correlation of HLA-DR4 gene complex with:
- Rheumatoid factor (RF)
- Anti-RA33/36 antibody
- Anti-keratin antibody (AKA) and
- Anti-perinuclear factor (APF)
- PCR-SSP method was used to examine the DR4 gene complex
- Anti-RA33/36 Ab and RF were tested by Western blot and latex agglutination test respectively
- AKA and APF were tested by the indirect immunofluorescence method
- DR4 gene complex was present in 60% pts; RF positivity was 68.9%
- DR4(+) pts had a higher RF positive rate (66.7%) than DR4(-) pts (33.3%)
- Anti-RA33/36 Ab was positive in 37.8% pts; was present in 33.3% DR4(+) pts and in 38.9% DR4(-) pts; no difference
- AKA (1:80) was positive in 28.9% pts; was present in 33.3% DR4(+) pts and in 22.2% DR4(-) pts; no significant difference
- APF could be detected in 53.3% of pts; was positive in 51.9% DR4(+) pts and 55.5% DR4(-) pts; no significant difference
- In addition, no association could be found between RF, anti-RA33/36 antibody, AKA and APF
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
Arthritis Research & Therapy, 12/19/09
Update on the genetic risk factors for rheumatoid arthritis
Expert Review of Clinical Immunology, 12/18/09
The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
Rheumatology International, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


